Alexandre Merlo

Alexandre Merlo

Auto-generated profile, based on publicly available information

Alexandre Merlo


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2014 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
NLNorma Vollmer Labarthe
Norma Vollmer Labarthe
JPJonimar Pereira Paiva
Jonimar Pereira Paiva
LRLarissa Reifur
Larissa Reifur
FMFlavya Mendes-De-Almeida
Flavya Mendes-De-Almeida
AMAlexandre Merlo
Alexandre Merlo
LALeucio Câmara Alves
Leucio Câmara Alves
Canine heartworm infections were frequently diagnosed in Brazil before the new millennium. After the year 2000, the frequency of diagnosis showed a sharp decline; however, a few years later, new evidence indicated that the parasite was still present and that canine infection rates seemed to be increasing. Therefore, an updated survey of canine heartworm prevalence was conducted in several locations in south, southeast, and northeast Brazil. Dogs from 15 locations having previously reported a high prevalence of heartworm infection were included in the survey according to defined criteria, including the absence of treatment with a macrocyclic lactone for at least 1 year. Blood samples from 1531 dogs were evaluated by an in-clinic immunochromatography test kit (Witness® Heartworm, Zoetis, USA) for detection of Dirofilaria immitis antigen. At each location, epidemiologic data, including physical characteristics and clinical signs reported by owners or observed by veterinarians, were recorded on prepared forms for tabulation of results by location, clinical signs, and physical characteristics. The overall prevalence of canine heartworm infection was 23.1%, with evidence of heartworm-infected dogs detected in all 15 locations studied. There was a tendency for higher prevalence rates in environmentally protected areas, despite some locations having less-than-ideal environmental temperatures for survival of vector mosquitoes. Among physical characteristics, it was noted that dogs with predominantly white hair coats and residing in areas with a high (≥20%) prevalence of heartworm were less likely to have heartworm infection detected by a commercial heartworm antigen test kit than were dogs with other coat colors. In general, dogs older than 2 years were more frequently positive for D. immitis antigen than were younger dogs. Clinical signs of heartworm infections were rare or owners were unable to detect them, and could not be used for reliable prediction of the presence of heartworm. These results indicate that the prevalence of D. immitis has increased in these areas of Brazil over the past few years. Small animal practitioners in these areas should include routine screening tests for heartworm infections in every dog’s annual evaluation protocol and make sure to have uninfected dogs on prevention.

8 May 2019 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
NLNatália Lôres Lopes
Natália Lôres Lopes
DCDiefrey Ribeiro Campos
Diefrey Ribeiro Campos
MMMarília Alves Machado
Marília Alves Machado
MAMariana Silva Revoredo Alves
Mariana Silva Revoredo Alves
MSManuela Silva Gomes de Souza
Manuela Silva Gomes de Souza
JFJulio Israel Fernandes
Julio Israel Fernandes
Oclacitinib is a Janus kinase (JAK) 1 enzyme inhibitor and blocks JAK1-dependent cytokines and is used to control pruritus. Studies available in cats are very limited and as there is a potential role for oclacitinib in the control of pruritus in this specie, the aim of this study was to evaluate the safety and clinical effects of oral oclacitinib maleate in healthy cats. Thirty mixed-breed cats weighing from 2.1 to 5.3 kg each were randomly allocated to three treatment groups of 10 animals each. Cats in two groups received oclacitinib at 1 mg/kg or 2 mg/kg q 12 h orally for 28 days. Cats in the third group were given placebo tablets (cornstarch) q 12 h orally for 28 days. Oclacitinib maleate was well tolerated during the study and few adverse events were observed in treated cats. Clinical signs of toxicity were not observed in any animals treated at 1 mg/kg. Gastrointestinal clinical signs observed in the 2 mg/kg group included vomiting in two of the 10 cats and soft stools in two cats. One cat treated with placebo also exhibited soft stools. No significant differences were observed between the groups for hematologic analyses performed during the study. There was a slight increase in neutrophils and monocytes and a decrease in eosinophil mean counts in treated cats. Mean renal and liver enzymes remained normal throughout the entire study. A small, but significant increase in fructosamine levels was observed for both treated groups compared with placebo; however, values remained within the normal reference range. There were no significant difference between treated groups and the placebo group for urine specific gravity, pH, or urine protein to creatinine ratio mean values. Oclacitinib maleate was well tolerated by cats at 1 mg/kg and 2 mg/kg and appeared to be safe for this species when administered orally twice daily for 28 days. More studies would be needed to demonstrate if oclacitinib maleate may be a suitable alternative to treat pruritic cats.

22 July 2016 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
MMMaria de Fátima Chicarino Varajão Moraes-Da-Silva
Maria de Fátima Chicarino Varajão Moraes-Da-Silva
FMFlavya Mendes-De-Almeida
Flavya Mendes-De-Almeida
LALivia Abdalla
Livia Abdalla
AMAlexandre Merlo
Alexandre Merlo
JPJonimar Pereira Paiva
Jonimar Pereira Paiva
NLNorma Vollmer Labarthe
Norma Vollmer Labarthe
Dog owners and veterinarians in small animal practices began to waive prevention of canine heartworm disease after heartworm infections seemed to have disappeared in Brazil. After 2013, infection rates rebounded, and an evaluation of the efficacy of chemoprophylactic drugs became necessary. Included in this re-evaluation was the efficacy of selamectin in client-owned dogs residing in a high infection-risk area. The preventive efficacy of selamectin was evaluated by the topical application of selamectin to 24 client-owned dogs at the recommended rate (minimum of 6 mg/kg) by a veterinarian monthly for 36 months. Blood samples were collected before the first treatment and at the end of the study for testing to detect microfilariae by the modified Knott’s test and Dirofilaria immitis antigens using a commercial antigen test. Exposure to risk of heartworm infection was confirmed by the presence of infection in dogs living in low-income communities within a 2 km radius from the homes of dogs in the study. The dogs were managed according to routine practice by the owners within each household throughout the study. All dogs tested negative by both tests after receiving topical treatment with selamectin monthly for 36 months. Testing of 204 dogs from the communities confirmed the presence of heartworm in the area by detection of microfilariae or D. immitis antigen in 44 dogs (21.6 %). Topical selamectin was 100 % effective for D. immitis prevention in 24 dogs that received monthly treatments by a veterinarian. Detection of heartworm infections in untreated dogs in the area suggests that clients need to be better informed regarding the prevalence of D. immitis and the importance of maintaining regular preventive treatments.

6 October 2020 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
BABruno Alberigi
Bruno Alberigi
JFJulio I. Fernandes
Julio I. Fernandes
JPJonimar P. Paiva
Jonimar P. Paiva
FMFlavya Mendes-De-Almeida
Flavya Mendes-De-Almeida
FKFabiana Knackfuss
Fabiana Knackfuss
NLNorma Labarthe
Norma Labarthe
Background: Dirofilaria immitisis a life-threatening nematode spreading globally. Arsenical treatment is currently recommended for removal of adult worms. However, arsenical treatment is not available in some countries, and there are dogs that cannot tolerate the rapid kill of adult worms; therefore, alternative adulticide slow-kill treatments are needed. Criticisms against the use of these alternative protocols include the potential for allowing disease to progress and for the development of ML-resistant worms.Methods: The efficacy of a protocol that includes semi-annual doses (i.e. every 6 months) of commercially available extended-release injectable moxidectin suspension (ProHeart®SR-12) with 30-day oral administration of doxycycline was studied in 20 dogs with naturally occurringD. immitisinfections. Each dog received treatment with ProHeart®SR-12 (0.5 mg moxidectin/kg) by subcutaneous injection and oral doxycycline (10 mg/kg/bid × 30 days) every 6 months until two consecutive negative antigen test results were obtained. Pulmonary and cardiac evaluations were performed by radiographic and echocardiographic parameters. Physical examinations, complete blood counts, clinical chemistry profiles, microfilariae and antigen tests were performed periodically.Results: At enrollment, all dogs were positive forD. immitisantigen and 18 were microfilaremic. On day 30, microfilaremia counts decreased, and all dogs became amicrofilaremic by day 150. On day 180, 11 dogs were antigen-negative, and 7 more became negative by day 360. The two remaining antigen-positive dogs converted to negative by day 540 or 810. All antigen tests performed 180 days after the first negative test were negative. There was no decline in cardiac performance of the dogs throughout the study. Overall, pulmonary clinical conditions, presence of worms by echocardiography, and enlargement of caudal and main pulmonary arteries improved after treatment. Physical examinations, complete blood count results, and clinical chemistry profiles were within normal reference values. Respiratory conditions were improved, no damage to the heart was observed, and the treatment protocol was well tolerated by the animals.Conclusions: This alternative adulticide treatment was efficacious and well tolerated in naturally infected dogs. The injectable formulation provides the advantage of having veterinarians able to administer, monitor, and assess the efficacy and condition of the dog throughout the treatment and post-treatment periods.

21 November 2024 in Animals
Verified
Journal Article
Open access
PDF file
CDCHRISTOS DADOUSIS
CHRISTOS DADOUSIS
AWAnthony David Whetton
Anthony David Whetton
KMKennedy Mwacalimba
Kennedy Mwacalimba
AMAlexandre Merlo
Alexandre Merlo
AWAndrea Wright
Andrea Wright
NGNophar Geifman
Nophar Geifman
Chronic kidney disease (CKD) is characterised by progressive kidney damage and encompasses a broad range of renal pathologies and aetiologies. In humans, CKD is an increasing global health problem, in particular in the western world, while in cats and dogs, CKD is one of the leading causes of mortality and morbidity. Here, we aimed to develop an enhanced understanding of the knowledge base related to the pathophysiology of renal disease and CKD in cats and dogs. To achieve this, we leveraged a text-mining approach for reviewing trends in the literature and compared the findings to evidence collected from publications related to CKD in humans. Applying a quantitative text-mining technique, we examined data on clinical signs, diseases, clinical and lab methods, cell types, cytokine, and tissue associations (co-occurrences) captured in PubMed biomedical literature. Further, we examined different types of pain within human CKD-related publications, as publications on this topic are sparser in companion animals, but with the growing importance of animal welfare and quality of life, it is an area of interest. Our findings could serve as substance for future research studies. The systematic automated review of relevant literature, along with comparative analysis, has the potential to summarise scientific evidence and trends in a quick, easy, and cost-effective way. Using this approach, we identified targeted and novel areas of investigation for renal disease in cats and dogs.

26 March 2008 in Veterinary Clinical Pathology
Verified
Journal Article
Closed access
PDF file
AMAlexandre Merlo
Alexandre Merlo
BRBárbara Cristina Gagliano Rezende
Bárbara Cristina Gagliano Rezende
MFMaria Luisa Franchini
Maria Luisa Franchini
PMPaula Rumy Gonçalves Monteiro
Paula Rumy Gonçalves Monteiro
SLSílvia Regina Ricci Lucas
Sílvia Regina Ricci Lucas